Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 No-Brainer Stocks You Can Buy Right Now


Some decisions are hard. Others, however, are so easy that they require much less thought.

Three Motley Fool contributors believe they've found stocks to buy that definitely fall into the latter category. Here's why they think (NYSE: ABBV), Pfizer (NYSE: PFE), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer stocks to buy right now.

Prosper Junior Bakiny (AbbVie): Pharma giant AbbVie isn't currently popular with investors. The company's shares are down by 14% year to date. It's no wonder: AbbVie's financial results are suffering due to its losing U.S. patent exclusivity for Humira, its best-selling medicine. Patent cliffs for therapies that generate billions in sales can be hard to navigate for drugmakers, and the market doesn't seem too confident that AbbVie will do a good job of it. That's a mistake.

Continue reading


Source Fool.com

AbbVie Inc. Stock

€176.74
-0.470%
AbbVie Inc. shows a slight decrease today, losing -€0.840 (-0.470%) compared to yesterday.
The stock is an absolute favorite of our community with 34 Buy predictions and no Sell predictions.
As a result the target price of 181 € shows a slightly positive potential of 2.41% compared to the current price of 176.74 € for AbbVie Inc..
Like: 0
Share

Comments